These are described in detail in the Methods section.
ReviewSeasonal influenza epidemiology in sub-Saharan Africa: a systematic review
Introduction
Pneumonia is the leading cause of paediatric mortality worldwide1, 2 and infections such as Streptococcus pneumoniae, Haemophilus influenzae type b, and respiratory syncytial virus are well recognised contributors to global disease burden.3, 4, 5, 6, 7 Recent studies have documented the substantial role of influenza in respiratory infection morbidity and mortality at all ages,8, 9, 10, 11, 12, 13, 14, 15, 16, 17 although results from other studies have cast doubt on some of the reports from elderly patients.18, 19 Modelling analyses have estimated yearly excess mortality attributable to influenza in the USA to be about 30 000 between 1976 and 2007, depending on the year and underlying assigned cause.16 Other studies have documented the effect of influenza on work11, 20 and school absenteeism11, 21, 22 and on the economic costs of influenza.23, 24, 25, 26, 27 Influenza also contributes to acute respiratory infection (ARI) burden by increasing the risk of bacterial pneumonia, particularly that caused by pneumococci.28, 29, 30, 31
About 1·1 billion people live in sub-Saharan Africa, an area that has high population growth rates, low life expectancy, and many of the world's poorest countries.32 Despite the abundance of information from many areas of the world, little is known about influenza epidemiology in sub-Saharan Africa,33 and no systematic review has been published. We aimed to help identify data gaps that might affect policy decisions (such as routine vaccine use and target groups and the need for antiviral drugs), to assess the state of knowledge on seasonal influenza epidemiology in sub-Saharan Africa, and to ascertain unique features of influenza epidemiology in the region. We concentrated on sub-Saharan Africa because epidemiological, socioeconomic, and vaccine policy factors in northern Africa are likely to be substantially different. We focused on seasonal human influenza because data on pandemic or avian and animal influenza are unlikely to greatly inform routine yearly influenza prevention and treatment decisions.
Section snippets
Search strategy and selection criteria
We searched the National Library of Medicine through PubMed for (“influenza” AND “Africa”) OR (“Africa” AND (“pneumonia” OR “acute respiratory infection”)) OR (“influenza” AND each individual sub-Saharan African country); sub-Saharan African countries were defined by the UN Educational, Scientific and Cultural Organization34 with the addition of Reunion. The search was limited to studies of people, studies published in English, French, or Portuguese, and studies published from Jan 1, 1980, to
Results
We screened the titles and abstracts of 1203 published articles (figure 1). 49 are included in this report.42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
Studies varied substantially on the basis of the number of years of assessment, age-groups included, number of influenza isolates obtained, testing methods implemented, and clinical case definitions
Discussion
As documented in a brief review published in 2002,93 little influenza surveillance infrastructure existed at that time in sub-Saharan Africa. Between 2002 and 2007, of the 46 WHO African Region countries, only South Africa, Senegal, and Madagascar routinely reported influenza activity to WHO, with sporadic reporting from Zambia, Uganda, Mauritius, Reunion, and Kenya.35, 36, 37, 38, 39, 40, 41 We found few published influenza epidemiology data in sub-Saharan Africa, which were concentrated in
Search strategy and selection criteria
References (126)
- et al.
Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial
Lancet
(2005) - et al.
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial
Lancet
(2005) - et al.
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Lancet
(2010) - et al.
Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective
Value Health
(2004) - et al.
The incidence of vaccine-preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia
Vaccine
(2000) - et al.
Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip—an inactivated split virion influenza vaccine—supports wider vaccine use
Vaccine
(2007) - et al.
Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community
Vaccine
(2002) - et al.
Immune response to influenza vaccination in community-dwelling Chinese elderly persons
Vaccine
(2006) - et al.
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study
Lancet
(2008) - et al.
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries
Vaccine
(2006)
The annual impact of seasonal influenza in the US: measuring disease burden and costs
Vaccine
Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan
Vaccine
Influenza virus strains in Nairobi, Kenya
J Clin Virol
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya
Lancet
Etiologic agents and outcome determinants of community-acquired pneumonia in urban children: a hospital-based study
J Natl Med Assoc
Influenza survey in Senegal
Trans R Soc Trop Med Hygiene
Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1
J Pediatr
Regional perspectives on influenza surveillance in Africa
Vaccine
Millennium Development Goals Report: 2005. United Nations, New York, NY, 2005
Pneumonia: the Forgotten Killer of Children
Global estimate of the incidence of clinical pneumonia among children under five years of age
Bull World Health Organ
Epidemiology and etiology of childhood pneumonia
Bull World Health Organ
The effectiveness of vaccination against influenza in healthy, working adults
N Engl J Med
Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly
N Engl J Med
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens
Arch Intern Med
Estimates of deaths associates with seasonal influenza—United States, 1976–2007
Morb Mortal Wkly Rep
A patient with fulminant influenza-related bacterial pneumonia due to Streptococcus pneumoniae followed by Mycobacterium tuberculosis infection
Intern Med
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
Int J Epidemiol
The impact of influenza on working days lost: a review of the literature
Pharmacoeconomics
Countywide school-based influenza immunization: direct and indirect impact on student absenteeism
Pediatrics
Effectiveness of school-based influenza vaccination
N Engl J Med
Societal and economic consequences of influenza
Manag Care
Socioeconomic impact of influenza on healthy children and their families
Pediatr Infect Dis J
Insights into the interaction between influenza virus and pneumococcus
Clin Microbiol Rev
Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3
Infect Immun
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection
J Immunol
Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity?
Epidemiol Infect
Sub-Saharan Africa
Influenza in Africa
PLoS Med
Sub-Saharan Africa
Influenza in the world: 1 October 2002–30 September 2003
Wkly Epidemiol Rep
Influenza in the world: 1 October 2003–30 September 2004
Wkly Epidemiol Rep
Summary of influenza activity: 1 September 2004–31 August 2005
Wkly Epidemiol Rep
Influenza in the world: 1 September 2005–31 January 2006
Wkly Epidemiol Rep
Influenza in the world: 1 February–30 September
Wkly Epidemiol Rep
Influenza in the world: 1 September 2006–31 January 2007
Wkly Epidemiol Rep
Influenza in the world
Wkly Epidemiol Rep
The association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso
Trop Med Int Health
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis
JAMA
Bilan de deu annees de surveillance de la grippe a Abidjan
Med Trop
Cited by (110)
Epidemiology of influenza in Nigeria: A secondary analysis of the sentinel surveillance data in Nigeria from 2010 – 2020
2024, Journal of Infection and Public HealthComputational analysis of drug like candidates against Neuraminidase of Human Influenza A virus subtypes
2020, Informatics in Medicine UnlockedCitation Excerpt :Influenza is a respiratory infection caused by influenza virus, which is a negative-sense, single-stranded member of the Orthomyxoviridae family of RNA viruses. It is known as an important cause of morbidity and mortality worldwide, especially during seasonal epidemics and pandemics [1]. Based on antigenic variation, the virus can be classified into four types as influenza A, B, C and D; however, types A, B and C are known to infect humans [2,3].
Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study
2019, The Lancet Child and Adolescent HealthThe efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review
2019, The Lancet Infectious DiseasesDeveloping a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG)
2019, VaccineCitation Excerpt :And despite the fact that Africa bears the brunt of the world's vaccine-preventable diseases [3], African nations are least likely to have functional NITAGs in place that provide timely, locally relevant, evidence-based vaccine recommendations that influence national policy decisions [2]. The burden of influenza in the tropics has been documented in recent studies [4–9]. Paediatric respiratory hospitalizations associated with influenza are more than three times higher in low- and middle-income countries (LMICs) compared to high income countries (HICs) (150 vs 48 per 100,000 children annually) [4].